Skip to main content

Advertisement

Table 4 Sensitivity analysis results. Costs in SEK 2004.

From: Non-pharmaceutical prevention of hip fractures – a cost-effectiveness analysis of a community-based elderly safety promotion program in Sweden

  Costs avoided Net costs QALYs Cost per QALY
Base case 6,522 134 -70,985 35 <0
Model parameters     
A. Fracture risk [39] 6,479,356 -28,207 35 <0
A. Fracture risk doubled 5,978,641 472,508 33 14,327
B. Mortality risk [40] 7,401,024 -949,875 29 <0
C. Medical treatment costs [21] 11,793,758 -5,342,609 35 <0
C. Medical treatment costs, average difference 6,420,258 30,891 35 879
1 year before and 2 years after hip fracture     
D. 2nd and following year costs [21] 6,709,090 -257,941 35 <0
E. Non-market productivity incl. [41] 6,789,172 -338,023 35 <0
E. Costs in added life-years [14] 447,200 6,003,949 35 170,907
F. Alternative QoL weights [42] 6,522,134 -70,989 48 <0
G. Discount rate 0% 7,535,125 -1,083,976 45 <0
G. Discount rate 5% 5,986,099 465,050 30 15,313
H. Mortality and hip fracture risks [39,40] 7,385,325 -934,176 29 <0
I. No costs or QoL effects after 1st year 1,935,529 4,515,620 22 202,041
J. Another disease; fracture risks doubled, no costs or QoL effects after 1st year 1,730,899 4,720,250 21 228,805
Program specific     
Program costs +25% 6,522,134 1,541,798 35 43,888
Program effectiveness: lowest 2,712,870 3,738,279 21 178,013
Program effectiveness: highest 12,534,792 -6,083,643 67 <0